Key market opportunities in the omics-based clinical trials sector include the rising adoption of personalized medicine, ...
Early-stage lung adenocarcinoma alters DNA methylation, mRNA transcription, and protein expression in adjacent tissues, exhibiting either steep changes at the tumor boundaries or shallow changes ...